David Sperandio

This inventor holds 20 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Orsobio, Inc., The Liver Company Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Sperandio. Retrieved from https://idiyas.com/inventor/david-sperandio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 13)

% Patents Active = 95.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 7.4

ph-index = 7

Forward Citations = 167(Granted Patents)

Company Filing History:

16 out of 946

Gilead Sciences, Inc.

The Liver Company Inc.

patent

4. 1 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Sulfinylaminobenzamide

Benzimidazole Derivatives

Imidazopyrimidine

Pyrazolo[1,5-A]pyrimidines

Anti-RSV Compounds

Nucleoside Analogs

Bromodomain Inhibitors

Antiviral Treatment

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12606522 - Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives (2026-04-21),

2. 12466849 - Anti-viral and anti-tumoral compounds (2025-11-11),

3. 12049439 - Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives (2024-07-30),

4. 11179397 - Imidazopyrimidine derivatives (2021-11-23),

5. 11136290 - Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives (2021-10-05),

6. 10174038 - Compounds and methods for antiviral treatment (2019-01-08),

7. 10017501 - Benzimidazole derivatives as bromodomain inhibitors (2018-07-10),

8. 9957275 - Pyrazolo[1,5-A]pyrimidines for antiviral treatment (2018-05-01),

9. 9951065 - Benzimidazole and imadazopyridine carboximidamide compounds (2018-04-24),

10. 9504689 - Compounds and methods for antiviral treatment (2016-11-29),

11. 9458145 - Benzimidazole derivatives as bromodomain inhibitors (2016-10-04),

12. 9255089 - Benzimidazolone derivatives as bromodomain inhibitors (2016-02-09),

13. 9238039 - Pyrazolo[1,5-A]pyrimidines for antiviral treatment (2016-01-19),

14. 9108953 - Quinoline derivatives as bromodomain inhibitors (2015-08-18),

15. 8999969 - Anti-RSV compounds (2015-04-07),

Title: The Innovative Journey of David Sperandio

Introduction: David Sperandio is a visionary inventor based in Palo Alto, CA, known for his groundbreaking contributions to various industries.

Latest Patents: David Sperandio holds several patents in the fields of technology, healthcare, and renewable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, David Sperandio has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, David Sperandio has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life, leading to successful partnerships and game-changing inventions.

Conclusion: David Sperandio's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.